Henry Schein, Inc. (NASDAQ:HSIC) Holdings Lifted by abrdn plc

abrdn plc boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 69.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,676 shares of the company's stock after purchasing an additional 22,495 shares during the quarter. abrdn plc's holdings in Henry Schein were worth $4,140,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Baystate Wealth Management LLC boosted its holdings in Henry Schein by 2,500.0% in the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company's stock worth $39,000 after acquiring an additional 500 shares in the last quarter. McGlone Suttner Wealth Management Inc. purchased a new stake in Henry Schein during the 4th quarter worth approximately $39,000. Neo Ivy Capital Management acquired a new position in Henry Schein during the 3rd quarter valued at approximately $46,000. Covestor Ltd raised its holdings in shares of Henry Schein by 22.8% in the third quarter. Covestor Ltd now owns 1,367 shares of the company's stock worth $102,000 after buying an additional 254 shares during the last quarter. Finally, Fifth Third Bancorp lifted its stake in shares of Henry Schein by 14.3% during the third quarter. Fifth Third Bancorp now owns 1,744 shares of the company's stock worth $129,000 after buying an additional 218 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insider Buying and Selling

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the business's stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares of the company's stock, valued at approximately $5,430,462.24. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Trading Down 0.1 %

Henry Schein stock traded down $0.10 during trading on Monday, hitting $73.03. The company had a trading volume of 743,703 shares, compared to its average volume of 1,075,420. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The company's 50 day simple moving average is $74.17 and its 200-day simple moving average is $72.41. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The stock has a market cap of $9.38 billion, a price-to-earnings ratio of 23.22, a price-to-earnings-growth ratio of 1.81 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.70 by ($0.04). The firm had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. Henry Schein's revenue was down 10.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.21 EPS. As a group, analysts expect that Henry Schein, Inc. will post 5.07 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have weighed in on HSIC shares. JPMorgan Chase & Co. boosted their price target on Henry Schein from $82.00 to $88.00 and gave the company an "overweight" rating in a research note on Wednesday, March 6th. Jefferies Financial Group boosted their price target on Henry Schein from $74.00 to $81.00 and gave the company a "hold" rating in a report on Wednesday, March 6th. Evercore ISI raised their price objective on shares of Henry Schein from $79.00 to $83.00 and gave the stock an "in-line" rating in a research note on Wednesday, February 28th. Piper Sandler increased their price target on shares of Henry Schein from $78.00 to $86.00 and gave the stock an "overweight" rating in a report on Monday, February 26th. Finally, SVB Leerink initiated coverage on shares of Henry Schein in a research report on Monday, February 26th. They issued a "market perform" rating and a $78.00 price objective for the company. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $81.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.